Management Sciences for Health

11/25/2025

📌 𝐌𝐚𝐫𝐤 𝐲𝐨𝐮𝐫 𝐜𝐚𝐥𝐞𝐧𝐝𝐚𝐫𝐬: Giving Tuesday is December 2!

We’re just days away from MSH’s first-ever Giving Tuesday fundraising campaign. But there is no need to wait until Tuesday to save a life!

Because of you, more people around the world in desperate need of health care can get it when they need it, where they need it.

💛Save a life today. Donate now: https://msh.org/donate/

GivingTuesday

11/24/2025

🎙️ President & CEO Marian Wentworth recently joined the CSIS | Center for Strategic & International Studies "Common Health" podcast for a conversation on her personal journey, leadership, and the future direction of Management Sciences for Health. She reflects on what it means to lead in a time of change and why MSH’s mission remains as vital as ever.

Give it a listen ⬇️https://www.csis.org/podcasts/commonhealth/marian-wentworth-msh-i-have-been-working-i-was-13

Marian Wentworth, President & CEO, Management Sciences for Health (MSH), reflects on the stunning year of 2025, a series of radical pivots for MSH.

11/23/2025

Nigeria’s progress on HPV vaccination is clear: scaling impact now requires sustained systems, not one-off campaigns. With over 12 million girls vaccinated, the priority is embedding HPV delivery into routine immunization through predictable financing, strengthened coordination, and state-owned policies.

New sub-national evidence from Kano, Kaduna, and Lagos provides a precise roadmap. The data show:

➡️ ₦9,000–₦14,000 (approximately USD $6-$9) per eligible girl is the cost of maintaining high coverage
➡️ Sustainable delivery depends on state-level budget lines and integrated planning
➡️ Cross-sector coordination, especially across health, education, and community structures, is essential
➡️ Local leadership drives results, exemplified by Kano’s rise from 4% to 86% coverage

These insights confirm what MSH and partners have long championed: HPV vaccination succeeds when countries lead, systems align, and financing is secured. Our work supports Nigeria to translate evidence into durable, state-led action that protects every girl from cervical cancer.

Learn more about how MSH and partners are strengthening Nigeria’s HPV vaccination systems: https://msh.org/projects/evidence-informed-technical-advocacy-for-hpv-vaccine-introduction-in-nigeria/

Evidence-Informed Technical Advocacy for HPV Vaccine Introduction in Nigeria Overview Nigeria has one of the highest burdens of cervical cancer in the

11/21/2025

How countries navigate donor transitions will determine whether they safeguard hard-won health gains, or risk losing them.

New research published in PLOS Medicine, co-authored by our colleague Justice Nonvignon, reinforces what we see across MSH’s work worldwide: successful transitions happen when countries lead the process, invest in domestic financing, and realign systems so programs continue sustainably. The paper highlights three essentials for a successful transition:

1️⃣ Joint, transparent leadership
2️⃣ Domestic financing that closes the gap left by donors
3️⃣ Realigning and strengthening systems—from budgeting and procurement to service delivery and governance—so programs are fully absorbed into national structures.

This reflects the work we do at MSH every day. We support ministries of health and finance to:

✔️ Co-develop and manage robust transition plans
✔️ Institutionalize budgeting, costing, procurement, and regulatory reforms
✔️ Strengthen supply chains and data systems
✔️ Integrate donor-supported services into national programs
✔️ Build the financial and technical capacity needed to sustain results long after aid ends

As global health financing shifts, one message is clear: country-led transitions succeed when leadership, financing, and systems strengthening move together.

Congratulations to Justice and colleagues for advancing this important conversation on sustainable, country-owned health systems.

Read the article: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004794

11/20/2025

“𝘖𝘶𝘳 𝘨𝘰𝘢𝘭 𝘪𝘴 𝘻𝘦𝘳𝘰 𝘤𝘦𝘳𝘷𝘪𝘤𝘢𝘭 𝘤𝘢𝘯𝘤𝘦𝘳 𝘤𝘢𝘴𝘦𝘴 𝘪𝘯 𝘕𝘪𝘨𝘦𝘳𝘪𝘢. 𝘛𝘳𝘶𝘦 𝘴𝘶𝘤𝘤𝘦𝘴𝘴 𝘸𝘪𝘭𝘭 𝘣𝘦 𝘸𝘩𝘦𝘯 𝘱𝘢𝘳𝘦𝘯𝘵𝘴 𝘸𝘢𝘭𝘬 𝘪𝘯𝘵𝘰 𝘩𝘦𝘢𝘭𝘵𝘩 𝘧𝘢𝘤𝘪𝘭𝘪𝘵𝘪𝘦𝘴 𝘢𝘴𝘬𝘪𝘯𝘨 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘏𝘗𝘝 𝘷𝘢𝘤𝘤𝘪𝘯𝘦 𝘧𝘰𝘳 𝘵𝘩𝘦𝘪𝘳 𝘥𝘢𝘶𝘨𝘩𝘵𝘦𝘳𝘴.” Dr. Ahmed Rufai, Director of Disease Control & Immunization, National Primary Health Care Development Agency (NPHCDA)

Health for women and girls remains central to a Nation's progress, and Nigeria is taking bold, evidence-informed steps to sustain HPV vaccination and prevent cervical cancer.

During his visit to Nigeria earlier this month, Dr. Dan Schwarz, MSH Chief Medical Officer, joined partners from Solina Centre for International Development and Research -SCIDaR and Women Advocates for Vaccine Access to convene national and state leaders for the Evidence for Informed Technical Advocacy Dissemination Workshop in Abuja.

With more than 12 million girls vaccinated since 2023, Nigeria now leads one of the world’s largest HPV vaccination campaigns. New evidence from Kano, Kaduna, and Lagos highlights the cost of sustaining HPV vaccination and underscores the need for strong state-level policies, dedicated budget lines, and multisectoral coordination.

Kano State’s jump from 4% to 86% coverage shows what strong leadership and collaboration can deliver. remains committed to supporting Nigeria’s continued progress toward eliminating cervical cancer.

Read the full recap from the discussions and the recommendations: https://msh.org/story/nigeria-charts-a-sustainable-path-for-hpv-vaccination/

11/18/2025

demands more than treatment, it requires innovation, partnership, and strong .

Through the Eliminate TB Project in , MSH and partners are transforming how TB is detected, prevented, and managed:

➡️ Faster, more accurate diagnosis with GeneXpert and digital X-ray technology
➡️ Expanded latent TB treatment to stop infection before it becomes disease
➡️ Stronger lab and surveillance systems that improve quality of care
➡️ Community and private-sector engagement to reach people wherever they seek services
➡️ Resilience in crisis, supporting integrated TB and HIV sercices

This is what country-led initiatives look like, and it’s bringing Ethiopia closer to a future free from TB. Learn more about the project and its impact so far: https://msh.org/story/strengthening-lab-capacity-to-save-lives-how-msh-is-helping-ethiopia-eliminate-tb/

Strengthening Lab Capacity to Save Lives: How MSH is Helping Ethiopia Eliminate TB By Jennifer Gardella Sitting in an outside courtyard at Yirgalem

11/17/2025

MSH at the Union World Conference on Lung Health 2025

For more than five decades, MSH has stood with national TB programs, local partners, and frontline health workers to strengthen the systems that prevent, find, and treat tuberculosis. This week, as the global TB community gathers in for , we remain focused on championing country-led, sustainable pathways to end TB.

Ending TB requires more than tools alone—it requires trusted partnerships, strong public health systems, and locally driven solutions that endure beyond cycles of global funding. Even amid shrinking international financing, countries like continue to show what sustained investment, technical leadership, and resilient systems can achieve.

At The Union 2025, MSH is excited to share insights from the US-funded Eliminate TB Project in Ethiopia, spotlighting innovations and approaches that are shaping stronger national responses across prevention, diagnosis, treatment, and community-based care.

Explore the link to learn more: https://lnkd.in/dhmxaK-E

Connect with us at the !

11/17/2025

As the global community marks the first World , we recognize Nigeria’s continued leadership and progress toward eliminating cervical cancer, and are honored to support these efforts.

Management Sciences for Health (MSH) is partnering with the Government of Nigeria to strengthen cervical cancer data systems and integrate standardized indicators into the National Health Management Information System (NHMIS) and DHIS2.

These steps will ensure that screening and treatment data are routinely captured, visible, and actionable across all levels of care, including:
➡️ Improving visibility and coordination across programs and partners
➡️ Strengthening accountability and performance management through data-informed decisions
➡️ Accelerating progress toward the World Health Organization (WHO) 90-70-90 cervical cancer elimination targets

This work builds on ’s growing cervical cancer portfolio in , including efforts to expand vaccination and improve prevention, screening, and treatment. Learn more about MSH’s cervical cancer work in Nigeria: https://msh.org/story/management-sciences-for-health-to-support-nigeria-in-strengthening-cervical-cancer-data-systems-and-integration-into-dhis2/



Federal Ministry of Health Nigeria Nigeria Centre for Disease Control

11/15/2025

With people at the center and with support from partners like the MSH-led, U.S. Government-funded SAFEMed Activity, Ukraine continues to strengthen its health system and expand access to medicines for more equitable health outcomes.

➡️Millions of prescriptions reimbursed through AMP, Ukraine’s flagship health financing reform
➡️More medicines coming to patients in 2026
➡️Thousands of health professionals trained

Read more in the October SAFEMed Activity Newsletter: https://msh.org/resources/safe-affordable-and-effective-medicines-for-ukrainians-safemed-activity-october-2025-monthly-newsletter/



Ministry of Health of Ukraine НСЗУ Національна служба здоров'я України Міністерство охорони здоров'я України

11/14/2025

✨ Last week, Nigeria took an important step toward stronger, more resilient health systems.

Management Sciences for Health (MSH) was proud to support the Federal Ministry of Livestock Development, the Federal Ministry of Health Nigeria, NAFDAC, and partners in validating the country’s first National Essential Veterinary Medicines List (NEVML) and accompanying guidelines.

This milestone matters. It equips with a clear, evidence-based, nationally owned reference for essential veterinary medicines—strengthening regulatory oversight, guiding procurement and training, and advancing responsible antimicrobial use across the One Health spectrum.

By grounding decisions in data and global best practices, Nigeria has the technical tools to drive sustainable improvements that protect both animal and human health.

We are honored to work alongside our colleagues in government and partners like World Organisation for Animal Health (WOAH) and FAO in supporting this critical step toward a healthier, safer future for communities across the country.

Read the full article by AgroNigeria : https://agronigeria.ng/fg-validates-nigerias-first-national-essential-veterinary-medicines-list-guidelines/

Learn more about our support to advancing Nigeria's One Health strategy: https://msh.org/projects/fleming-fund-country-grant-for-nigeria-phase-2/

11/11/2025

This week, Management Sciences for Health (MSH) is joining global health organizations at , contributing to the conversation: Are we investing in the right levers to eliminate malaria for good?

If you're in Toronto for , catch MSH’s Justice Nonvignon on Wednesday, together with other experts, at the symposium Malaria Eradication in Our Lifetime: Don’t Stop Believing, hosted by the Gates Foundation and Medicines for Malaria Venture (MMV).

He’ll speak on the topic “Can We Afford Elimination? Can we afford NOT to achieve elimination?” exploring sustainable financing for malaria elimination and why smart investments now determine whether progress accelerates or stalls as global health funding shifts.

Learn more about the session: https://msh.org/events/malaria-eradication-in-our-lifetime/

Malaria Eradication in Our Lifetime: Don’t Stop Believing Wednesday, November 12, 2025, 7:00–8:45 AM | Toronto, Ontario, Canada This is a sponsored

11/10/2025

𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐭𝐡𝐫𝐢𝐯𝐞, 𝐚𝐧𝐝 𝐫𝐞𝐟𝐨𝐫𝐦𝐬 𝐭𝐚𝐤𝐞 𝐬𝐡𝐚𝐩𝐞 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧.

In October’s 𝐒𝐀𝐅𝐄𝐌𝐞𝐝 𝐍𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫, we highlight the life-changing work supported by the Activity, including insights from the regional meeting showcasing the impact of the SAFEMed-supported Affordable Medicines Program (AMP).

Read the full newsletter to learn how collaboration is driving improved access to medicines across : https://msh.org/resources/safe-affordable-and-effective-medicines-for-ukrainians-safemed-activity-october-2025-monthly-newsletter/



НСЗУ Національна служба здоров'я України; Міністерство охорони здоров'я України; Медичні закупівлі України